Pharmazeutische Marktforschung

Gesundheit und Wohlbefinden sind ein wichtiger Teil des Lebens.  

These sectors relate to the development, manufacture, and marketing of medicines.  The global revenue of the pharmaceutical industry is more than $1 trillion. Almost half of this figure comes from two countries: the US and Canada. It is by far the most profitable industry of all. The primary and generic pharmaceutical companies lead the way in the industry.

Einige der Durchbrüche in der Branche kommen von spezialisierten Pharmaunternehmen. Einige dieser Unternehmen haben weniger Mitarbeiter als eine einzelne Abteilung in einem der größeren Unternehmen. Diese kleinen Unternehmen haben einen enormen Einfluss auf die Patienten. Sie konzentrieren sich auf Therapiebereiche und Nischenmärkte. Diese Unternehmen zeigen, wie ein gezielter Ansatz zu Ergebnissen führen kann. Einige Unternehmen konzentrieren sich ausschließlich auf eine Krankheit. Andere behandeln Leiden, die nur eine Minderheit der Bevölkerung betreffen.

The US pharmaceutical market dominates the rest of the world. The US is an innovator and a booster in the field of medical research and development. Their R&D benefits the international pharmaceutical industry. Still, one of the top conditions affecting US patients is diabetes. Oncology and autoimmune diseases are also the focus of much research in the US. Pfizer, Johnson & Johnson, and Merck & Co. are the largest companies on the US market.

Trends auf dem Pharmamarkt

Public Relations (PR) and Advertising are powerful for Pharma companies.  One of the most prominent is the consumer as customer. Biotech stories are starting to proliferate. One such story involves the use of gene therapy to regrow the skin of a little boy.  As drugs get personalized, stories such as these are capturing imaginations. They are also piquing people’s interest in the sector.  

Patient stories can be powerful.  Negative publicity can also be influential.  One pharma company made headline news for charging $1,000 per day to treat hepatitis, creating a slew of negative publicity.  It’s a brave – and complex new world for biotech and pharmaceutical companies.

There are several challenges in the pharmaceutical industry. These include policy reforms. For example, healthcare officials are likely to overhaul the Affordable Care Act soon. Another problem is the impact of new technologies. Industry players are still doubtful about the effects of these technologies. It is unclear how they will affect drug development and commercialization.  Gene therapy and Gene editing are also gaining more headlines on opportunities and challenges in those sectors.

Globale Pharmachancen

Pharmaceutical sales are the largest in the US and Europe. Developed markets for pharmaceuticals comprise the United States and Western Europa. Canada, Japan, and Australia are also part of this market.  The United States sells approximately 33%, Western Europe, 22%, and China, 10%. Japan accounts for 9% Latin America, 7%, and Russia, 4%. South Korea, India, Indonesia, and Australia are below 3%. 

Pharma Influencer Marketing

One of the digital trends in pharma is influencer marketing. An influencer is one who is active in one or more of the social channels, with a large follower base. Pharma companies have been using influencers. These influencers have been reporting on their use of certain drugs and devices. They are also influencing people’s behavior in the area of disease prevention. Influencers can also encourage adherence to treatment protocols.  Support groups can be highly influential in treatment and patient behavior.

Alternde Bevölkerungen

Einer der Wachstumstreiber der Pharmaindustrie ist die alternde Bevölkerung in den USA und in den meisten Industrieländern. Ein weiterer Wachstumsfaktor ist die Zunahme von Menschen, die einen ungesunden Lebensstil pflegen. Zu diesen schlechten Entscheidungen gehören mangelnde tägliche Bewegung und ungesunde Essgewohnheiten.

The USA and Europe are leaders in pharmaceutical development and use. Other areas like India and China have seen growth in recent years in the life science markets. The cause of this growth is an increasing demand for devices and products. It is also because of substantial capital opportunities. 

Lösungen für die Pharmamarktforschung

SIS International Research has over 40+ years of experience in Markt Research and Strategy Consulting in the Pharmaceutical industry.  We conduct research with patients, caretakers, physicians, payors, influencers, regulators, and other stakeholders.

Wir bieten an:

• Schwerpunktgruppen
• Online-Insight-Communitys
• Tiefgründige Interviews
• Online-Umfragen
• Mehrländer- und internationale Marktforschung
• Market Entry, Sizing, and Opportunity
• Strategische und Wettbewerbsanalyse